These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7919275)

  • 1. [An experimental model of pseudotuberculosis infection in monkeys].
    Marakulin IV; Darmov IV; Pogorel'skiĭ IP; Drobkov VI; Pautov VN
    Biull Eksp Biol Med; 1994 Jul; 118(7):59-62. PubMed ID: 7919275
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on aerosol Yersinia pseudotuberculosis infection of guinea-pigs.
    Velianov D; Nikolova S; Naĭdenski Kh; Raducheva T; Kŭsovski V; Grigoriev I; Ilieva L
    Acta Microbiol Bulg; 1993; 30():3-10. PubMed ID: 8285130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis of the experimental pseudotuberculosis infection by immunization with porin from Yersinia pseudotuberculosis].
    Darmov IV; Marakulin IV; Pogorel'skiĭ IP; Novikova OD; Portniagina OIu; Solov'eva TF
    Biull Eksp Biol Med; 1999 Feb; 127(2):221-3. PubMed ID: 10095962
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute and chronic experimental infection processes caused by Yersinia pseudotuberculosis and evaluation of interleukin action on their development and outcome.
    Tseneva GY; Voskressenskaya EA; Simbirtsev AS; Shestakova IV; Demakova TE; Chmyr IA
    Adv Exp Med Biol; 2003; 529():177-9. PubMed ID: 12756754
    [No Abstract]   [Full Text] [Related]  

  • 5. [Morphogenesis of experimental infection following intraperitoneal and subcutaneous inoculation of animals with Pasteurella (Yersinia) pseudotuberculosis].
    Anichkov NM
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 41():167-71. PubMed ID: 4620293
    [No Abstract]   [Full Text] [Related]  

  • 6. Defensive function of phagocytes in pseudotuberculosis.
    Plekhova NG; Somova-Isachkova LM; Shubin FN
    Adv Exp Med Biol; 2003; 529():161-4. PubMed ID: 12756750
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility to Yersinia pseudotuberculosis infection is linked to the pattern of macrophage activation.
    Tansini A; de Medeiros BM
    Scand J Immunol; 2009 Apr; 69(4):310-8. PubMed ID: 19284495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
    Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
    Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Creatine kinase activity in guinea pig tissues in experimental pseudotuberculosis].
    Krutetskaia NI; Sokolov IN; Stefanov VE; Krutetskaia ZI; Lyzlova SN
    Vopr Med Khim; 1986; 32(4):59-62. PubMed ID: 3532531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
    Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
    Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Yersinia pseudotuberculosis infection].
    Takeda N
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):496-9. PubMed ID: 10088455
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
    Monnazzi LG; Carlos IZ; de Medeiros BM
    Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic necrotizing factor is an effective immunogen in a Yersinia pseudotuberculosis aerosol mouse model.
    Mou S; Cote CK; Worsham PL
    Adv Exp Med Biol; 2012; 954():179-81. PubMed ID: 22782762
    [No Abstract]   [Full Text] [Related]  

  • 15. Trypsin-like proteinase and its endogenous inhibitor from Yersinia pseudotuberculosis. Biological activity.
    Burtseva TI; Loenko YN
    Biochemistry (Mosc); 1999 Sep; 64(9):986-9. PubMed ID: 10521713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correction of phagocytosis defects in pseudotuberculosis infection with immunomodulators of natural origin].
    Zaporozhets TS; Krylova NV; Ivanushko LA; Gazha AK; Smolina TP; Besednova NN
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):55-8. PubMed ID: 9432849
    [No Abstract]   [Full Text] [Related]  

  • 17. [State of the kidneys in patients with pseudotuberculosis].
    Karbysheva NV
    Klin Med (Mosk); 1985 May; 63(5):123-5. PubMed ID: 3900559
    [No Abstract]   [Full Text] [Related]  

  • 18. [Status of the liver in different forms of pseudotuberculosis].
    Podlevskiĭ AF; Vlasov NN
    Klin Med (Mosk); 1986 Nov; 64(11):91-5. PubMed ID: 3546931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects of pseudotuberculosis].
    Dudoĭ MKh
    Voen Med Zh; 1975 Sep; (9):59-60. PubMed ID: 1103463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenal cortex function in patients with Far East scarlatina-like fever (pseudotuberculosis)].
    Malyĭ VP; Somov OG
    Klin Med (Mosk); 1978 Aug; 56(8):100-1. PubMed ID: 359913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.